Objectives. Extrapulmonary tuberculosis (TB) constitutes the main cause of classic fever of unknown origin (FUO) in many populations. The aim of this study was to improve the diagnostic field of the disease using a nested polymerase chain reaction (PCR) assay, specific for the IS6110 insertion element of Mycobacterium tuberculosis complex, in order to achieve a more timely diagnosis and treatment. Setting. Twenty-four, HIV-negative classic FUO patients who were admitted to the Regional Hospital of Alexandroupolis between April 1997 and July 1999. Subjects and design. The above patients were considered as putative extrapulmonary TB after 3 weeks of in-patient investigation and underwent exhaustive examination for diagnosis of the disease.
For this purpose, specimens were obtained from peripheral blood and bone marrow from these patients, as well as from damaged tissues, and analysed by both PCR and conventional methods. Anti-tuberculous treatment was initiated in 16 out of 24 patients and the response to this regimen was considered as the final criterion for diagnosis of tuberculosis. Results. Extrapulmonary TB was established in 11 patients. The PCR-based methodology, when applied to samples derived from bone marrow aspirations and suspected damaged tissues, was able to diagnose 10 of them, whereas the conventional methods were able to detect only two. Conclusions. Our results confirm the diagnostic value of molecular detection of M. tuberculosis in cases of FUO, thus supporting the application of PCR in tissue samples suspected of bacillus infection. Furthermore, our studies demonstrate that bone
Introduction
Fever of unknown origin (FUO) presents one of the most difficult diagnostic problems in everyday clinical practice. This disorder is defined by temperatures higher than 38.38C, with duration of fever of more than 3 weeks and failure of diagnosis after 1 week of in-patient investigation [1] . Although this definition was modified in order to facilitate the diagnostic research, final diagnosis depends on the combination of`intelligent and intensive' investigation. The wide availability of ultrasonography, computed tomography (CT) and magnetic resonance imaging (MRI) has contributed to the earlier detection of lymphomas and solid tumours in patients previously thought to have FUO. Additionally, the high specificity and sensitivity of various immunological tests have reduced the number of undiagnosed autoimmune diseases [1] . However, infections, especially extrapulmonary tuberculosis (TB), still constitute the leading cause of FUO [1±3] .
Extrapulmonary TB involves relatively inaccessible sites, and usually fewer bacilli than those found in pulmonary disease are responsible for much greater damage [2] . Early diagnosis is of major importance in the control of TB [2, 4] . Acid-fast staining of clinical specimens, followed by culture confirmation, remain the cornerstone of TB diagnosis [2] . These conventional bacteriological methods are time-consuming and their sensitivity is low when the clinical samples contain a small number of microorganisms [2] . The combination of a small number of bacilli present in inaccessible sites makes bacteriological confirmation of extrapulmonary TB very difficult.
In recent years, polymerase chain reaction (PCR)-based protocols raised hopes for reliable, convenient and early diagnosis of TB [5, 6] . The insertion sequence IS6110 has been successfully used as a target for PCR amplification in clinical samples by many investigators [5±8] . The sensitivity and specificity of IS6110 amplification are variable in different laboratories and depend on the source of the clinical sample, the localization of TB, the coexistence of HIV infection and other technical parameters [6±12]. The utility of IS6110 sequence amplification for the detection of mycobacteraemia in the peripheral blood of patients suffering from pulmonary TB, or in HIV-positive patients with extrapulmonary localization of the disease, was easy to demonstrate, probably due to the high load of microorganisms present in the above situations [13± 15]. However, the value of this approach for HIVnegative patients with extrapulmonary TB remains to be established.
For this purpose, 24 HIV-negative patients suffering from FUO were investigated for the presence of bacilli by amplifying a selected fragment of the IS6110 sequence of Mycobacterium tuberculosis complex using a nested PCR protocol. Nested PCR was performed in peripheral blood mononuclear cells, in bone marrow aspiration samples (an easily accessible and often involved site in the dissemination of the disease), and in specimens obtained from the sources suspected of bacillus contamination when they were available. In contrast to FUO patients who were found negative for Mycobacterium sequences, those found positive when treated with anti-tuberculous regimen were cured, thus illustrating the value of this PCR-based protocol for the early recognition of FUO caused by extrapulmonary TB.
Materials and methods

Patients
Twenty-four HIV-negative, non-neutropenic patients who were admitted to the Regional Hospital of Alexandroupolis between April 1997 and July 1999, and who fulfilled the criteria of classic FUO, were investigated for bacillus dissemination. Molecular detection of M. tuberculosis complex was performed because extrapulmonary TB was suspected and/or no definitive diagnosis was established 3 weeks after admission to hospital. None of these patients had ever received BCG vaccination. Two of the patients (1 and 2 of Table 1 ) who had previously received anti-cancer therapy had recovered normal leucocyte count a few weeks before the initiation of symptoms.
Anti-tuberculous therapy (isoniazid 300 mg day 21 , rifampicin 600 mg day 21 and ethambutol 25 mg kg 21 day 21 ) was initiated in all PCR-positive patients, as well as in six PCR-negative patients who were seriously ill and/or were deteriorating very rapidly. In the rest of the PCR-negative patients, an alternative diagnosis was established soon after the application of PCR, as shown in the Table 2 .
Sample collection for PCR analysis
A total of 59 samples were analysed by PCR in 24 patients. Specimens were obtained from fluids or tissues with evidence of M. tuberculosis infection and from mononuclear cells isolated from bone marrow aspiration or from peripheral blood (PBMC). More specifically, tissue samples were collected from 11 In these patients, after a follow-up period of 5±17 months, the final diagnosis remained unchanged.
patients out of 24 (pleural effusion, 4; pericardial effusion, 1; lymph node, 4; and ascetic fluid, 2). Specimens from bone marrow and peripheral blood were obtained from all 24 patients (Tables 1 and 2 ).
Acid-fast stain and bacilli culture All 11 samples from the fluids and tissues suspected of Mycobacterium infection were investigated for the presence of acid-fast bacilli by Ziehl±Neelsen, cultured on Loewenstein±Jensen medium (bioMe Ârieux, France) and examined histologically. Liquid culturing systems were not available in the microbiology laboratory of our hospital during the period of this study. Additionally, all 24 specimens obtained from bone marrow aspiration and most of the samples collected from peripheral blood were analysed for the presence of bacilli by the above traditional techniques. Sputum samples were collected as routine from all 24 patients and investigated by traditional diagnostic procedures. These specimens were not analysed by PCR systematically, because no evidence of pulmonary disease was advocated.
DNA extraction
For isolation of mononuclear cells, 5 mL of peripheral blood or bone marrow aspiration were collected in EDTA anticoagulated tubes during the period of in-patient investigation. Cells were separated by density gradient centrifugation (lymphocyte separation medium, Gibco-BRL, Life Technologies, Paisley, UK). Cell pellets from ascetic, pleural or pericardial fluid were obtained after centrifugation at 1500 g About 3±5 3 10 6 cells or 20±40 mg of tissue (lymph node) were diluted in 1 mL of lysis buffer (100 mmol L 21 NaCl, 10 mmol L 21 tris-HCl pH 7.4, 25 mmol L 21 EDTA pH 8 and 0.5% SDS). Lysozyme (1 mg mL 21 , Sigma Chemical Co., St Louis, MO, USA) was added and the samples were incubated for 4 h at room temperature (not exceeding 238C). Thereafter, 20 mg mL 21 proteinase K was added and the samples were incubated for an additional 12±16 h at 508C. The samples were extracted once with phenol-chloroform and twice with chloroform, and finally nucleic acids were precipitated with ethanol. Precipitated nucleic acids were dissolved in 80±150 ml sterile distilled water.
Nested PCR
A nested PCR protocol was used in order to amplify a fragment of the IS6110 sequence of M. tuberculosis complex. The positions and sequences of the primers utilized were selected with the aid of the Oligo-5 software (NBI, Plymouth, MN). The set of primers utilized to obtain the results presented herein was selected as the best of three primer sets tested. One commercial kit (AMS 19, Clonit, Milano-Italy) was also compared (Fig. 1a, lane p1) . All the designed primers, as well as the primer pair from the kit, were utilized in amplification reactions using different dilutions of positive control of M. tuberculosis complex DNA. The following set provided the best amplification results in primary and secondary reactions: TJ5, 59-CCG CAA AGT GTG GCT AAC-39 and TJ3, 59-ATC CCC TAT CCG TAT GGT G-39 (positions 608 and 998, respectively, and amplified product 409 bp; Fig. 1a , lane p2) were the outer primers. OLI5, 59-AAC GGC TGA TGA CCA AAC-39 and STAN3, 59-GTC GAG TAC GCC TTC TTG TT-39 (positions 667 and 963, respectively, and amplified product 316 bp; Fig. 1a , lanes 1±10) were used as nested primers. Extracted DNA (0.5±1 mg) was used in a 50 mL PCR reaction using 200 mmol L 21 of each deoxynucleotide triphosphate, 60 pmol of each primer, and 2.0 U Taq polymerase (Promega, Madison, WI, USA) in a PCR buffer supplied by the manufacturer. Thereafter, an appropriate amount of primary PCR product, usually 2±3 mL, was used for the nested PCR. Nested PCR was carried out in a 50 mL reaction using the same buffer as above. The conditions of primary PCR were as follows: 2 min at 948C followed by 35 cycles (948C for 80 s, 578C for 60 s, 728C for 70 s), and then 5 min at 728C. The conditions for nested PCR were as follows: 2 min at 948C followed by 35 cycles (948C for 60 s, 608C for 60 s, 728C for 60 s) and then, after the last cycle, 5 min at 728C. All PCR amplifications were carried in the PCR-engine apparatus PTC-200, MJ Research (Watertown, MA, USA). The PCR products were analysed in 2% agarose gels (Gibco-BRL).
Hybridization
Ten microlitres of each nested PCR product were transferred onto Hybontd-N1 nylon membranes (Amersham Pharmacia Biotech, UK) by standard alkaline protocol [16] . The 59 end biotinylated sequence 59-CTC GTC CAG CGC CGC TTC G 39 starting on the position 762 of IS6110 was used as hybridization probe. This probe has previously been used successfully to detect the IS6110 sequence of M. tuberculosis complex [9] . Prehybridization (3 h) and hybridization (12 h) were performed in 6 3 SSC, 5 3 Denhart's solution, 200 mg mL 21 sperm fish DNA and 0.5% SDS buffer in 558C. Subsequently the membranes were washed in 2 3 SSC 1 0.5% SDS buffer at room temperature for 30 min and then washed twice in 0.5 3 SSC 1 0.1% SDS buffer for 20 min at 578C. Detection of hybridized sequences was carried out using the PhotoGene detection system (Gibco-BRL) according to the manufacturer's instructions.
Results
From April 1997 to July 1999, 42 classic FUO patients were admitted to our hospital. The applied diagnostic procedures allowed us to define the cause of the problem after 3 weeks of in-patient research in only 18 of them. Despite intensive investigation, the aetiology of FUO in the other 24 patients 4 2 0 K . R I T I S et al. Table 1 . Secondary PCR products, except in lane 6 (patient 6 of Table 1 ), were obtained using DNA isolated from bone marrow aspiration. Lane M: 100 bp ladder (Gibco). Lane B: blank. Lanes p1 and p2: primary PCR products (10 mL in each lane) using the same amount of positive control template. Primers from AMS 19 commercial kit were used for PCR product of lane p1, and primers TJ5/TJ3 were also used in order to obtain the product of lane p2. (b) Hybridization of nested PCR products from the 10 FUO patients with tuberculosis (lanes 1±10). Lane p2: primary PCR product of positive control, obtained after using the TJ5/TJ3 primers. (c) Agarose gel electrophoresis and hybridization of nested PCR products in two positive and two negative patients. Lanes 1 and 6: positive control. Lanes 2 and 7: patient 2 ( Table 1) . Lanes 3 and 8: patient 5 (Table 1) . Lanes 4 and 9: patient 2 ( Table 2) . Lanes 5 and 10: patient 10 ( Table 2) . Lane M: 100 bp ladder (Gibco). Lane B: blank.
remained elusive. In such circumstances, extrapulmonary TB constitutes a frequent cause of FUO [1, 3, 17] , and nationwide experience in Greece ( http://www.ncsi.gr/gr/greece/greece.html) indicates that the incidence of TB in some geographical populations remains a common clinical problem. Therefore, we considered all the 24 patients as putative extrapulmonary TB patients, and each underwent exhaustive examination for TB. Due to the long time required for the traditional TB detection protocols, we decided to investigate in parallel the potential benefit of incorporating a PCRbased detection protocol in our efforts to establish extrapulmonary TB as the cause of FUO definitively. We initiated anti-tuberculous treatment in 16 out of the 24 patients (Tables 1 and 2 ), based on the PCR data and/or clinical evidence for the disease. Failure of fever to respond over a 6-week period suggested an alternative diagnosis and the response to therapy, in combination with other clinical and laboratory data, was used to establish the final diagnosis of tuberculosis and validate the molecular analysis results. We tried three sets of PCR primers based on the published nucleotide sequence of the IS6110 insertion element of M. tuberculosis complex (GenBank accession no. M29899). A commercially available primer pair and two positive control samples (one commercially available and one derived from a lymph node drainage that was found to be contaminated with M. tuberculosis by conventional methods) were also used. Hybridization was performed in all nested PCR products positive for a 316 bp band, in order to confirm our results, and was positive in all cases (Table 1, Fig. 1b) . Similar hybridization experiments failed to detect any hybridizing sequences in secondary PCR products from samples that were found negative for a distinct 316 bp band (Table 2, Fig. 1c) . Based on the PCR results, our 24 patients were separated into the following two groups.
FUO patients that were positive for IS6110. This first group (Table 1, Figs. 1a and b) consisted of 10 patients (mean age 60.4 6 15.47 years) who were found positive for the IS6110 sequence by the PCR amplification. None of these patients was found positive for acid-fast bacilli using the Ziehl±Neelsen staining protocol and only two of them (patients 2 and 8) were found positive using cultures on Loewenstein±Jensen medium in specimens originated from lymph nodes. Furthermore, patients 1, 2, 5, 6, 7 and 9 (Table 1) received broad-spectrum antibiotics before anti-tuberculous trial. No response was observed, thus reducing the probability that other bacterial infections, such as Staphylococcus and Streptococcus, were the cause of the FUO, and making it more likely that M. tuberculosis was the causative agent.
PCR amplification readily detected the IS6110 sequence in nine out of 10 patients in samples originated from bone marrow aspiration. One patient (patient 6) who was negative using bone marrow aspirates was found positive for the IS6110 sequence in specimens obtained from pleural effusion. In six out of 10 PCR-positive patients, samples from sites suspected of bacilli infection were available and the IS6110 was detected in all of them as well. The sources of specimens in these six patients were lymph node (patients 2, 3 and 8), pericardial fluid (patient 4), ascetic fluid (patient 5) and pleural fluid (patient 6). In patients 4 and 5, amplification of M. tuberculosis was also achieved in PBMC.
Anti-tuberculous treatment was initiated in all PCR-positive patients (Table 1) . Eight out of the 10 patients were cured after this regimen and this fact was considered as the final criterion to establish their diagnosis of TB. Unfortunately, patients 5 and 10 died 4 and 12 days, respectively, after the isolation of the IS6110 sequence, probably due to the delayed application of anti-tuberculous treatment. Patient 5 died from a dramatic liver dysfunction and the death of patient 10 occurred because of acute respiratory failure. In these two patients, despite the failure of traditional methods, the application of molecular analysis was delayed and thus we were unable to provide a more timely diagnosis.
FUO patients negative for IS6110 sequences. The second group constituted 14 patients (mean age 55.5 6 10.35 years, Table 2 ). The presence of M. tuberculosis could not be established in any of these patients using either traditional methods (Ziehl± Neelsen staining and cultures on Loewenstein± Jensen medium) or our PCR-based protocol. In five patients (1, 7, 8, 9 and 10) , specimens from tissues suspected of bacillus contamination were available; however, even in these cases, the IS6110 sequence was not amplified. An anti-tuberculous regimen trial was administered in patients 2, 5, 6, 7, 9 and 11, but only patient 2 responded. With the exception of patient 2, the definitive diagnosis in these patients was determined later to be other than TB ( Table 2) . Most of the patients in this group were followed up for 5±17 months after the final diagnosis was established (Table 2) . During this period, this final diagnosis remained unchanged.
Patient 2 within the IS6110 negative group, who responded to anti-tuberculous treatment, did not constitute an exception to the rule. TB pericarditis was suspected in this case; however, the patient refused to allow pericardial puncture. It is reasonable to believe that the PCR protocol would have readily detected the IS6110 sequence in this sample if it had been available.
Discussion
Extrapulmonary TB represents the main cause of FUO in many populations [1] . In our study, extrapulmonary TB was demonstrated in 11 out of 24 classic FUO, HIV-negative hospitalized patients. The 24 analysed patients were selected from 42 FUO patients because evidence suggested extrapulmonary TB as a putative cause of the disease. More clinical details about the 24 FUO patients are described in Tables 1 and 2 . The final diagnosis was based on conventional and molecular laboratory data, the course of the disease and eventually the response to an anti-tuberculous regimen. The incidence of TB in our geographical area is high and represents a common clinical problem. The purified protein derived (PPD) skin test is positive in nearly 50% of people with a mean age of 60 years and BCG vaccination was never performed in this population group [18] . Thus, the usefulness of the PPD skin test in diagnosing TB was limited in the majority of our patients.
Our clinical and laboratory data illustrated that 11 out of 24 investigated patients were suffering from extrapulmonary TB. Traditional laboratory methods were able to diagnose only two of them (patients 2 and 8; Table 1 ). The failure of bacillus isolation in the other nine patients was probably due to the fact that the specimens obtained contained bacteria below the detection limit of traditional culture methods. However, this small number of bacilli can cause tuberculous damage [2] . PCR amplification was able to diagnose 10 out of these 11 patients, demonstrating the validity of this alternative method for the detection of bacilli in specimens containing numbers of bacteria undetectable by culture methods.
Liver and bone marrow tissues are frequently involved in TB dissemination [2, 19] . Additionally, it has also been reported that PCR is a reliable method in specimens obtained from bone marrow or liver biopsy for detection of TB [11] . The present study is based mainly on specimens originated from bone marrow because liver biopsies are not performed as a routine examination in our division, and material from bone marrow aspiration is obtained more easily and safely than liver biopsy. Furthermore, a larger amount of possible infected tissue can be obtained in this way.
The IS6110 sequence was amplified in all TB cases when the source of damage was accessible, and in most of the samples (nine out of 10 PCRpositive patients, Table 1 ) originated from bone marrow. Remarkably, the PCR-based analysis resolved undiagnosed TB cases when applied to bone marrow aspirates from 13 patients where the suspected site of Mycobacterium infection was inaccessible or unknown (Tables 1 and 2 ). Thus, in four out of 11 patients eventually diagnosed with extrapulmonary TB (patients 1, 7, 9 and 10; Table 1 ) bone marrow-based nested PCR assays constituted the only laboratory evidence of M. tuberculosis infection. DNA amplification of Mycobacterium does not always mean viable bacilli [20] and the PCR result has to be evaluated in combination with other clinical and laboratory findings [21] . In our study, the positive PCR result in combination with FUO was taken as a sign of disease in progress and treated successfully with an anti-tuberculous regimen. Mycobacterium was undetectable by either traditional or IS6110 amplification techniques in the second group of patients (Table 2 ) and TB could not be established retrospectively (except in patient 2) after the anti-tuberculous regimen trial. These findings confirmed the absence of false-positive results by our PCR protocol. False-positive results have been reported for specimens containing mycobacteria other than TB (MOTT) [22, 23] . The lack of HIV-positive patients in this study, who are more often infected by mycobacteria of other species, may explain the absence of false-positive results.
In HIV-positive patients, the sensitivity of IS6110 amplification in peripheral blood is high because of a large amount of mycobacteraemia [2, 13, 24] . Condos et al. [15] observed that PCR in peripheral blood is of great value for the diagnosis of pulmonary TB. However, the diagnostic yield of PCR in HIV-seronegative patients suffering from extrapulmonary TB was very low in peripheral blood, bone marrow, urine, and pleural or pericardial fluid [13, 14, 25, 26] . Furthermore, earlier reports failed to demonstrate the validity of PCR amplification for diagnosis FUO in HIV-negative cases of extrapulmonary TB [13, 25, 26] . Although our study included a relatively small number of FUO patients, it nevertheless demonstrated the high sensitivity of the applied PCR protocol in bone marrow and/or in samples obtained from suspected tissues of Mycobacterium contamination. The discrepancy between earlier reports and ours is most likely due to applied experimental parameters for PCR analysis, as well as the fact that FUO in extrapulmonary disease may constitute a critical clinical sign of a suitable amount of disseminated bacilli detectable by PCR but not isolated by conventional culture protocols.
The duration of illness may be of importance since the DNA of bacilli was easily detected in the peripheral blood of patients 4 and 5 (Table 1) , in whom the symptoms had been present for a long time (10 and 6 months, respectively), but not from peripheral blood of the other patients.
The timely utilization of the PCR protocol in classic FUO patients is of great importance; however, it should be combined with other clinical findings and intensive investigation of these patients. In most patients in this study, risk factors for extrapulmonary disease that accompany fever (other non-HIV causes of immunosuppression, diabetes mellitus, hepatic cirrhosis, familiar or personal history of pulmonary TB, epidemiological data, etc.) have constituted criteria for timely molecular detection of M. tuberculosis. When FUO is present as the only finding and/or if the clinician is in a diagnostic dilemma, molecular detection of bacilli should be attempted as soon as possible. Atypical clinical manifestations and delayed diagnosis are also common in the elderly [27] . We believe that the application of molecular analysis in patients 5 and 10 ( Table 1 ) was delayed and thus we were unable to provide more timely diagnosis and treatment.
In conclusion, we demonstrated that tissue specimens suspected of bacillus infection are the best material for PCR amplification of the IS6110 sequence of M. tuberculosis complex in HIV-negative patients with extrapulmonary disease presenting with classic FUO. When the extrapulmonary site of TB is inaccessible or unknown, we have also shown that a bone marrow-based nested PCR protocol can be successfully used for diagnosis of TB. We propose that an early application of the described PCR-based protocols can provide a more timely diagnosis and treatment of TB.
